Pepluanin A is a natural compound used in biochemical and pharmaceutical research. It exhibits significant anti-inflammatory activity by inhibiting the production of pro-inflammatory mediators such as nitric oxide and prostaglandin E2, and suppresses the expression of key inflammatory enzymes, including inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2). This makes it a potential candidate for treatments of chronic inflammatory diseases. Additionally, Pepluanin A demonstrates antimicrobial effects, particularly against gram-positive bacteria and certain fungi, with potential as a lead compound for anti-infective drugs. It also shows cytotoxic effects against certain cancer cell lines by inhibiting tumor cell proliferation, suggesting applications in oncology and chemotherapy development. Its bioactivity profile supports further investigation as a lead in anti-inflammatory, antimicrobial, and anticancer drug research.